Editorial
https://doi.org/10.52872/001c.28174
How the limited recognition of WHO-approved COVID-19 vaccines harm researchers of the low-and middle-income countries - A call for action
Ahmed Negida
Hazem S. Ghaith
Ulrick S Kanmounye
Abstract
Immunizing most of the global population with efficacious vaccines is the safest, fastest, and most reliable solution to emerge from the current COVID-19 pandemic. Extensive research efforts have produced a few vaccines with proven efficacy and acceptable safety profiles to achieve this purpose. Nonetheless, the limited manufacturing capacity and the logistics of vaccine approvals, production, shipment, and distribution to the target population, lead to significant delays that require both prioritizations of the vulnerable population groups and equitable distribution of the vaccines around the world
Keywords
Hrčak ID:
262904
URI
Publication date:
27.5.2021.
Visits: 654 *